| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Dwight Evans PA03 | 2 | −$16.0K | Trimmed Nov 21, 25 | |
| Lisa McClain MI09 | 1 | 2 | −$8.0K | Sold Oct 31, 25 |
| Valerie Hoyle OR04 | 1 | 1 | +$0 | Sold Sep 23, 25 |
| Adam Smith WA09 | 1 | −$8.0K | Sold Aug 8, 25 | |
| Rob Bresnahan PA08 | 1 | 1 | +$0 | Sold May 15, 25 |
| Jefferson Shreve IN06 | 1 | −$32.5K | Sold May 12, 25 | |
| Julie Johnson TX32 | 2 | −$16.0K | Sold Apr 1, 25 | |
| James French Hill AR02 | 1 | −$32.5K | Sold Jan 31, 25 | |
| Gilbert Cisneros CA31 | 1 | +$8.0K | Bought Jan 24, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Nov 21, 25 | Dwight Evans PA03 | Self | Sell (part) | $1,001 - $15,000 | May 15, 26 (175d) | |
| Nov 21, 25 | Dwight Evans PA03 | Self | Sell | $1,001 - $15,000 | Dec 19, 25 (28d) | |
| Oct 31, 25 | Lisa McClain MI09 | Spouse | Sell | $1,001 - $15,000 | Nov 21, 25 (21d) | |
| Oct 30, 25 | Lisa McClain MI09 | Spouse | Sell | $1,001 - $15,000 | Nov 21, 25 (22d) | |
| Oct 30, 25 | Lisa McClain MI09 | Spouse | Buy | $1,001 - $15,000 | Nov 21, 25 (22d) | |
| Sep 23, 25 | Valerie Hoyle OR04 | Spouse | Sell | $1,001 - $15,000 | Oct 10, 25 (17d) | |
| Aug 8, 25 | Adam Smith WA09 | Spouse | Sell | $1,001 - $15,000 | Aug 8, 25 (0d) | |
| May 15, 25 | Rob Bresnahan PA08 | Self | Sell | $1,001 - $15,000 | May 31, 25 (16d) | |
| May 12, 25 | Jefferson Shreve IN06 | Self | Sell | $15,001 - $50,000 | Jun 22, 25 (41d) | |
| Apr 1, 25 | Julie Johnson TX32 | Joint | Sell | $1,001 - $15,000 | May 14, 25 (43d) | |
| Feb 25, 25 | Rob Bresnahan PA08 | Self | Buy | $1,001 - $15,000 | Mar 27, 25 (30d) | |
| Jan 31, 25 | James French Hill AR02 | Self | Sell | $15,001 - $50,000 | Feb 4, 25 (4d) | |
| Jan 24, 25 | Gilbert Cisneros CA31 | Self | Buy | $1,001 - $15,000 | Feb 11, 25 (18d) | |
| Jan 15, 25 | Julie Johnson TX32 | Joint | Sell (part) | $1,001 - $15,000 | Feb 12, 25 (28d) | |
| Oct 29, 24 | Valerie Hoyle OR04 | Spouse | Buy | $1,001 - $15,000 | Sep 12, 25 (318d) |
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| May 20, 2026 | Robbins LarryDirector | Sale at price 93.45 - 96.28 per share. | 3.37M | $317.47M |
| May 13, 2026 | Brown C David IiDirector | Stock Award(Grant) at price 97.15 per share. | 1.5K | $150.00K |
| May 13, 2026 | Kirby John ScottDirector | Stock Award(Grant) at price 97.15 per share. | 1.4K | $140.58K |
| May 13, 2026 | Sansone Guy PDirector | Stock Award(Grant) at price 97.15 per share. | 1.4K | $140.58K |
| May 13, 2026 | Aguirre FernandoDirector | Stock Award(Grant) at price 97.15 per share. | 1.6K | $151.84K |
| May 13, 2026 | Balser Jeffrey R M.D., Ph.D.Director | Stock Award(Grant) at price 97.15 per share. | 2.1K | $199.94K |
| May 13, 2026 | Norwalk Leslie VDirector | Stock Award(Grant) at price 97.15 per share. | 1.4K | $140.58K |
| May 7, 2026 | Mandadi TilakOfficer | Sale at price 89.58 per share. | 69.6K | $6.23M |
| Mar 30, 2026 | Joyner John DavidChief Executive Officer | Stock Award(Grant) at price 71.82 per share. | 86.3K | $6.20M |
| Mar 30, 2026 | Nelson Steven HOfficer | Stock Award(Grant) at price 71.82 per share. | 22.3K | $1.60M |
| Mar 30, 2026 | Mandadi TilakOfficer | Stock Award(Grant) at price 71.82 per share. | 22.3K | $1.60M |
| Mar 30, 2026 | Shah Prem SOfficer | Stock Award(Grant) at price 71.82 per share. | 25.1K | $1.80M |
| Mar 30, 2026 | Capozzi Heidi BOfficer | Stock Award(Grant) at price 71.82 per share. | 10K | $720.00K |
| Mar 30, 2026 | Compton-Phillips AmyOfficer | Stock Award(Grant) at price 71.82 per share. | 5.6K | $399.97K |
| Mar 30, 2026 | Clark James DavidOfficer | Stock Award(Grant) at price 71.82 per share. | 11.1K | $799.93K |
| Mar 30, 2026 | Newman BrianChief Financial Officer | Stock Award(Grant) at price 71.82 per share. | 19.5K | $1.40M |
| Mar 30, 2026 | Khichi Samrat SGeneral Counsel | Stock Award(Grant) at price 71.82 per share. | 12.5K | $899.98K |
| Mar 18, 2026 | Gallina John EDirector | Stock Award(Grant) at price 71.86 per share. | 582 | $41.82K |
| Nov 19, 2025 | Brown C David IiDirector | Stock Award(Grant) at price 76.04 per share. | 1.8K | $134.97K |
| Nov 19, 2025 | Kirby John ScottDirector | Stock Award(Grant) at price 76.04 per share. | 1.7K | $125.62K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -6.1 | 7.2 | -10.1 | 16.0 | 9.2 | 13.7 | 0.9 | -10.1 | -8.8 | 2.4 | +10.6% | ||
| 2025 | 25.8 | 16.4 | 3.1 | -1.5 | -4.0 | 7.7 | -10.0 | 17.8 | 3.1 | 3.7 | 2.8 | -1.2 | +76.8% |
| 2024 | -5.8 | 0.0 | 7.2 | -15.1 | -12.0 | -0.9 | 2.2 | -5.1 | 9.9 | -10.2 | 6.0 | -25.0 | −43.1% |
| 2023 | -5.3 | -5.3 | -11.0 | -1.3 | -7.2 | 1.6 | 8.0 | -12.7 | 7.1 | -1.2 | -1.5 | 16.2 | −15.3% |
| 2022 | 3.2 | -2.7 | -2.4 | -5.0 | 0.6 | -4.2 | 3.3 | 2.6 | -2.8 | -0.7 | 7.6 | -8.5 | −9.7% |
| 2021 | 4.9 | -4.9 | 10.4 | 1.6 | 13.1 | -3.5 | -1.3 | 4.9 | -1.8 | 5.2 | -0.2 | 15.8 | +51.0% |
| 2020 | -8.7 | -12.7 | 0.3 | 3.7 | 6.5 | -0.9 | -3.1 | -1.3 | -6.0 | -4.0 | 20.9 | 0.8 | −8.1% |
| 2019 | 0.0 | -11.8 | -6.7 | 0.8 | -3.7 | 4.0 | 2.5 | 9.0 | 3.5 | 5.3 | 13.4 | -1.3 | +13.4% |
| 2018 | 8.5 | -13.9 | -8.2 | 12.2 | -9.2 | 1.5 | 0.8 | 16.0 | 4.6 | -8.0 | 10.8 | -18.3 | −9.6% |
| 2017 | -0.1 | 2.2 | -2.6 | 5.0 | -6.8 | 4.7 | -0.7 | -3.2 | 5.1 | -15.7 | 11.8 | -5.4 | −8.1% |
| 2016 | -1.2 | 0.6 | 6.8 | -3.1 | -4.0 | -0.7 | -3.2 | 0.7 | -4.7 | -5.5 | -8.6 | 2.6 | −19.3% |
| 2015 | 1.9 | 5.8 | -0.6 | -3.8 | 3.1 | 2.4 | 7.2 | -9.0 | -5.8 | 2.4 | -4.7 | 3.9 | +1.5% |
| 2014 | -5.4 | 8.0 | 2.4 | -2.9 | 7.7 | -3.8 | 1.3 | 4.0 | 0.2 | 7.8 | 6.5 | 5.4 | +34.6% |
| 2013 | 5.9 | -0.2 | 7.6 | 5.8 | -1.0 | -0.7 | 7.5 | -5.6 | -2.2 | 9.7 | 7.5 | 6.9 | +48.0% |
| 2012 | 2.4 | 8.0 | -0.7 | -0.4 | 0.7 | 4.0 | -3.2 | 0.7 | 6.3 | -4.2 | 0.2 | 4.0 | +18.6% |
| 2011 | -1.6 | -3.3 | 3.8 | 5.5 | 6.8 | -2.9 | -3.3 | -1.2 | -6.5 | 8.2 | 6.9 | 5.0 | +17.3% |
| 2010 | 0.5 | 4.3 | 8.3 | 1.0 | -6.2 | -15.3 | 4.7 | -12.1 | 16.6 | -4.3 | 2.9 | 12.2 | +7.9% |
| 2009 | -6.5 | -4.2 | 6.8 | 15.6 | -6.2 | 6.9 | 5.1 | 12.1 | -4.7 | -1.2 | -12.2 | 3.9 | +12.1% |
| 2008 | -2.1 | 3.8 | 0.3 | -0.3 | 6.0 | -7.5 | -7.8 | 0.3 | -8.0 | -8.9 | -5.6 | -0.7 | −27.7% |
| 2007 | 8.9 | -6.6 | 8.7 | 6.2 | 6.3 | -5.4 | -3.5 | 7.5 | 4.8 | 5.1 | -3.8 | -0.8 | +28.6% |
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Buy / hold / sell counts